Short answer · Medically reviewed summary · Last updated: 2026-04-08
Achromatopsia is classified under the ICD-10-CM code H53.51 (Achromatopsia), while in the legacy ICD-9-CM coding system, it was historically categorized under 368.51. These codes are essential for medical billing, clinical documentation, and accessing specialized vision services for those living with this rare cone-photoreceptor disorder. What is the clinical definition of Achromatopsia? Achromatopsia is a rare, non-progressive inherited retinal disorder characterized by the complete or partial absence of functional cone photoreceptors in the retina.
Achromatopsia is classified under the ICD-10-CM code H53.51 (Achromatopsia), while in the legacy ICD-9-CM coding system, it was historically categorized under 368.51. These codes are essential for medical billing, clinical documentation, and accessing specialized vision services for those living with this rare cone-photoreceptor disorder.
Achromatopsia is a rare, non-progressive inherited retinal disorder characterized by the complete or partial absence of functional cone photoreceptors in the retina. Individuals with Achromatopsia experience total color blindness, severe light sensitivity (photophobia), and significantly reduced visual acuity, usually stabilizing at around 20/200. Because the condition affects the cones—the cells responsible for color vision and daytime sharpness—the world is viewed primarily through the rod cells, which are better suited for low-light environments but lack the ability to distinguish color or fine detail.
Diagnosis of Achromatopsia typically involves a comprehensive evaluation by a pediatric ophthalmologist or a retinal specialist. Clinical testing often includes an Electroretinogram (ERG), which measures the electrical response of the retina; in patients with Achromatopsia, the photopic (cone) response is absent or severely diminished, while the scotopic (rod) response remains largely normal. Once confirmed, the ICD-10 code H53.51 is used to facilitate insurance coverage for low-vision aids, specialized tinted contact lenses, and educational support services.
Yes, Achromatopsia is a genetic condition, most commonly inherited in an autosomal recessive pattern. This means that an individual must inherit two mutated copies of a specific gene—most frequently CNGA3, CNGB3, GNAT2, PDE6C, or PDE6H—to manifest the disease. Genetic counseling is highly recommended for families to understand the 25% recurrence risk for each pregnancy when both parents are asymptomatic carriers. Currently, 118 members of the DiseaseMaps.org community have shared their journey with Achromatopsia, highlighting the importance of genetic testing in confirming the specific underlying mutation.
Living with Achromatopsia involves navigating significant visual limitations that impact daily life. Managing these challenges often requires a multidisciplinary approach:
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.